Rentokil Initial plc Key Executives
This section highlights Rentokil Initial plc's key executives, including their titles and compensation details.
Find Contacts at Rentokil Initial plc
(Showing 0 of )
Rentokil Initial plc Earnings
This section highlights Rentokil Initial plc's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2024 | 2025-03-07 | N/A | N/A |
| Read Transcript | Q2 | 2024 | 2024-07-26 | N/A | N/A |
| Read Transcript | Q4 | 2023 | 2024-03-11 | N/A | N/A |
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial and residential customers. The company also provides hygiene services, including the provision and maintenance of products, such as soap and hand sanitizer dispensers, hand dryers, air care and purification, cubicle and surface sanitizers, feminine hygiene units, toilet paper dispensers, and floor protection mats. In addition, it engages in the supply and laundering of workwear, uniforms, cleanroom uniforms, and protective equipment. Further, the company installs and services interior and exterior plant displays, flowers, replica foliage, Christmas decorations, and ambient scenting for commercial businesses; offers property care services consisting of damp proofing, property conservation, and woodworm and wood rot treatment; and provides a range of specialist cleaning services, such as graffiti removal deep cleaning of kitchens and washrooms, trauma cleaning, and flood or fire damage cleaning, as well as specialist industrial cleaning and disinfection services, including the professional and discreet disinfection of areas that have been exposed to bio-hazardous situations, such as crime and trauma scenes, prison cells, void properties, emergency vehicles, and healthcare establishments. Additionally, it offers a range of healthcare waste management services comprising the collection, disposal, and recycling of hazardous and offensive waste produced by businesses and organizations associated with the provision of healthcare; and color-coded sharps disposal bins to deal with various types of waste. Rentokil Initial plc was founded in 1903 and is headquartered in Crawley, the United Kingdom.
$20.91
Stock Price
$10.51B
Market Cap
-
Employees
Crawley, None
Location
Financial Statements
Access annual & quarterly financial statements for Rentokil Initial plc, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Revenue | $5.44B | $5.38B | $3.71B | $2.95B | $2.79B |
| Cost of Revenue | $4.71B | $927.00M | $2.74B | $2.24B | $2.14B |
| Gross Profit | $726.00M | $4.45B | $977.00M | $714.80M | $653.00M |
| Gross Profit Ratio | 13.36% | 82.75% | 26.31% | 24.20% | 23.41% |
| Research and Development Expenses | $7.00M | $- | $5.00M | $5.00M | $- |
| General and Administrative Expenses | $- | $- | $- | $- | $- |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $- | $2.87B | $479.00M | $348.60M | $352.00M |
| Other Expenses | $170.00M | $953.00M | $- | $- | $- |
| Operating Expenses | $177.00M | $3.82B | $479.00M | $348.60M | $352.00M |
| Cost and Expenses | $4.89B | $4.75B | $3.22B | $2.59B | $2.49B |
| Interest Income | $36.00M | $25.00M | $5.00M | $800.00K | $2.30M |
| Interest Expense | $192.00M | $189.00M | $74.00M | $33.30M | $40.30M |
| Depreciation and Amortization | $320.00M | $475.00M | $386.00M | $326.50M | $324.70M |
| EBITDA | $990.00M | $1.16B | $767.00M | $656.00M | $581.00M |
| EBITDA Ratio | 18.21% | 21.53% | 20.65% | 22.21% | 20.83% |
| Operating Income | $549.00M | $625.00M | $498.00M | $366.20M | $301.00M |
| Operating Income Ratio | 10.10% | 11.63% | 13.41% | 12.40% | 10.79% |
| Total Other Income Expenses Net | $-144.00M | $-132.00M | $-21.00M | $-22.00M | $-64.00M |
| Income Before Tax | $405.00M | $493.00M | $287.00M | $317.00M | $221.50M |
| Income Before Tax Ratio | 7.45% | 9.17% | 7.73% | 10.73% | 7.94% |
| Income Tax Expense | $98.00M | $112.00M | $64.00M | $61.90M | $43.50M |
| Net Income | $307.00M | $381.00M | $232.00M | $263.00M | $186.00M |
| Net Income Ratio | 5.65% | 7.09% | 6.25% | 8.90% | 6.67% |
| EPS | $0.12 | $0.15 | $0.12 | $0.14 | $0.10 |
| EPS Diluted | $0.12 | $0.15 | $0.12 | $0.14 | $0.10 |
| Weighted Average Shares Outstanding | 2.53B | 2.52B | 2.00B | 1.86B | 1.85B |
| Weighted Average Shares Outstanding Diluted | 2.53B | 2.53B | 2.01B | 1.87B | 1.86B |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | December 31, 2024 | June 30, 2024 | December 31, 2023 | June 30, 2023 | December 31, 2022 | June 30, 2022 | December 31, 2021 | June 30, 2021 | December 31, 2020 | June 30, 2020 | December 31, 2019 | June 30, 2019 | December 31, 2018 | June 30, 2018 | December 31, 2017 | June 30, 2017 | December 31, 2016 | June 30, 2016 | December 31, 2015 | June 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.73B | $2.71B | $2.70B | $2.67B | $2.14B | $1.57B | $1.50B | $1.46B | $1.53B | $1.28B | $1.39B | $1.29B | $1.30B | $1.18B | $1.18B | $1.23B | $1.18B | $987.10M | $903.70M | $855.30M |
| Cost of Revenue | $2.39B | $2.32B | $2.31B | $2.31B | $1.86B | $1.38B | $683.30M | $1.28B | $603.60M | $1.19B | $568.30M | $-9.00M | $514.20M | $- | $474.90M | $- | $376.10M | $- | $459.50M | $769.70M |
| Gross Profit | $341.00M | $385.00M | $399.00M | $363.00M | $284.20M | $191.90M | $812.30M | $179.00M | $922.70M | $93.50M | $817.90M | $1.30B | $782.00M | $1.18B | $703.80M | $1.23B | $804.90M | $987.10M | $444.20M | $85.60M |
| Gross Profit Ratio | 12.49% | 14.23% | 14.76% | 13.59% | 13.27% | 12.21% | 54.31% | 12.27% | 60.45% | 7.29% | 59.00% | 100.70% | 60.33% | 100.00% | 59.71% | 100.00% | 68.15% | 100.00% | 49.15% | 10.01% |
| Research and Development Expenses | $7.00M | $- | $7.00M | $- | $5.00M | $- | $5.00M | $- | $6.80M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| General and Administrative Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Selling General and Administrative Expenses | $- | $- | $2.87B | $- | $2.00B | $- | $1.60B | $100.00K | $1.50B | $100.00K | $1.52B | $100.00K | $1.37B | $4.00M | $1.33B | $3.40M | $1.20B | $4.30M | $968.70M | $3.00M |
| Other Expenses | $106.00M | $64.00M | $- | $- | $- | $- | $-1.23B | $-1.16B | $-1.26B | $-1.04B | $-1.15B | $-998.80M | $- | $- | $- | $- | $- | $- | $- | $- |
| Operating Expenses | $113.00M | $64.00M | $3.75B | $58.00M | $2.60B | $23.00M | $1.23B | $1.16B | $1.26B | $1.04B | $1.15B | $998.80M | $982.40M | $1.04B | $561.90M | $620.10M | $656.60M | $888.00M | $1.26B | $4.50M |
| Cost and Expenses | $2.50B | $2.38B | $2.31B | $2.31B | $1.86B | $1.38B | $1.31B | $1.30B | $1.34B | $1.19B | $1.28B | $1.17B | $1.50B | $1.04B | $1.04B | $620.10M | $1.03B | $888.00M | $1.72B | $774.20M |
| Interest Income | $- | $24.00M | $31.00M | $17.00M | $42.00M | $7.00M | $2.50M | $1.70M | $2.80M | $3.40M | $8.70M | $2.00M | $23.20M | $22.20M | $21.20M | $20.60M | $20.20M | $18.70M | $18.90M | $19.90M |
| Interest Expense | $- | $96.00M | $101.00M | $88.00M | $59.50M | $19.50M | $15.70M | $18.00M | $32.10M | $46.40M | $30.80M | $26.00M | $- | $- | $- | $- | $- | $- | $- | $- |
| Depreciation and Amortization | $155.00M | $165.00M | $121.00M | $234.00M | $134.60M | $153.40M | $74.30M | $145.20M | $81.00M | $152.30M | $130.40M | $174.60M | $100.30M | $91.80M | $95.20M | $92.50M | $123.80M | $107.90M | $97.60M | $94.30M |
| EBITDA | $465.00M | $525.00M | $520.00M | $597.00M | $418.80M | $345.30M | $254.00M | $301.40M | $268.10M | $245.10M | $241.20M | $291.10M | $269.20M | $206.00M | $251.90M | $251.30M | $278.50M | $210.50M | $225.80M | $182.90M |
| EBITDA Ratio | 17.03% | 19.40% | 19.23% | 22.35% | 19.55% | 21.98% | 16.98% | 20.67% | 17.57% | 19.10% | 17.40% | 22.57% | 20.77% | 17.52% | 21.37% | 20.37% | 23.58% | 21.33% | 24.99% | 21.38% |
| Operating Income | $228.00M | $321.00M | $399.00M | $363.00M | $284.20M | $191.90M | $187.60M | $156.20M | $187.10M | $92.80M | $110.80M | $116.50M | $168.90M | $114.20M | $156.70M | $158.80M | $154.70M | $102.60M | $128.20M | $88.60M |
| Operating Income Ratio | 8.35% | 11.86% | 14.76% | 13.59% | 13.27% | 12.21% | 12.54% | 10.71% | 12.26% | 7.23% | 7.99% | 9.03% | 13.03% | 9.71% | 13.29% | 12.87% | 13.10% | 10.39% | 14.19% | 10.36% |
| Total Other Income Expenses Net | $-76.00M | $-68.00M | $-148.00M | $-130.00M | $-150.20M | $-34.70M | $-14.90M | $-11.90M | $-19.10M | $-31.00M | $113.90M | $-15.00M | $-392.50M | $-4.70M | $-36.00M | $434.10M | $-26.60M | $-22.20M | $-39.40M | $-14.20M |
| Income Before Tax | $152.00M | $253.00M | $251.00M | $233.00M | $129.80M | $157.20M | $172.70M | $144.30M | $164.00M | $57.50M | $221.80M | $101.50M | $-223.60M | $109.50M | $120.70M | $592.90M | $128.10M | $80.40M | $88.80M | $70.20M |
| Income Before Tax Ratio | 5.57% | 9.35% | 9.28% | 8.72% | 6.06% | 10.01% | 11.55% | 9.90% | 10.74% | 4.48% | 16.00% | 7.87% | -17.25% | 9.31% | 10.24% | 48.06% | 10.85% | 8.15% | 9.83% | 8.21% |
| Income Tax Expense | $41.00M | $57.00M | $57.00M | $55.00M | $26.30M | $37.70M | $32.30M | $29.60M | $28.80M | $14.70M | $28.90M | $25.80M | $39.00M | $23.20M | $17.30M | $13.30M | $25.40M | $15.30M | $20.30M | $14.40M |
| Net Income | $111.00M | $196.00M | $196.00M | $185.00M | $107.80M | $124.20M | $144.00M | $119.20M | $138.90M | $47.00M | $195.50M | $88.00M | $-184.60M | $86.30M | $103.40M | $579.60M | $102.70M | $65.10M | $68.50M | $55.80M |
| Net Income Ratio | 4.07% | 7.24% | 7.25% | 6.93% | 5.03% | 7.90% | 9.63% | 8.17% | 9.10% | 3.66% | 14.10% | 6.82% | -14.24% | 7.34% | 8.77% | 46.98% | 8.70% | 6.60% | 7.58% | 6.52% |
| EPS | $0.04 | $0.08 | $0.08 | $0.07 | $0.05 | $0.07 | $0.08 | $0.06 | $0.08 | $0.03 | $0.11 | $0.05 | $-0.10 | $0.05 | $0.06 | $0.31 | $0.06 | $0.04 | $0.04 | $0.03 |
| EPS Diluted | $0.04 | $0.08 | $0.08 | $0.07 | $0.05 | $0.07 | $0.08 | $0.06 | $0.07 | $0.03 | $0.10 | $0.05 | $-0.10 | $0.05 | $0.06 | $0.31 | $0.06 | $0.04 | $0.04 | $0.03 |
| Weighted Average Shares Outstanding | 2.53B | 2.53B | 2.52B | 2.51B | 2.22B | 1.85B | 1.85B | 1.86B | 1.85B | 1.85B | 1.84B | 1.85B | 1.84B | 1.85B | 1.86B | 1.84B | 1.85B | 1.84B | 1.82B | 1.84B |
| Weighted Average Shares Outstanding Diluted | 2.53B | 2.53B | 2.53B | 2.53B | 2.22B | 1.87B | 1.87B | 1.86B | 1.86B | 1.86B | 1.86B | 1.86B | 1.84B | 1.85B | 1.86B | 1.84B | 1.85B | 1.83B | 1.83B | 1.83B |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $925.00M | $1.55B | $2.17B | $668.40M | $1.95B |
| Short Term Investments | $2.00M | $1.00M | $1.00M | $1.60M | $172.20M |
| Cash and Short Term Investments | $927.00M | $1.55B | $2.17B | $670.00M | $2.12B |
| Net Receivables | $909.00M | $880.00M | $830.00M | $527.00M | $504.60M |
| Inventory | $229.00M | $207.00M | $200.00M | $135.70M | $131.30M |
| Other Current Assets | $22.00M | $62.00M | $- | $8.90M | $81.20M |
| Total Current Assets | $2.09B | $2.70B | $3.24B | $1.34B | $2.84B |
| Property Plant Equipment Net | $963.00M | $951.00M | $949.00M | $625.60M | $620.20M |
| Goodwill | $5.16B | $5.02B | $5.12B | $1.84B | $1.61B |
| Intangible Assets | $1.93B | $2.00B | $7.32B | $2.16B | $1.92B |
| Goodwill and Intangible Assets | $7.09B | $7.02B | $12.44B | $4.01B | $3.53B |
| Long Term Investments | $64.00M | $122.00M | $187.00M | $54.00M | $77.50M |
| Tax Assets | $- | $- | $43.00M | $41.60M | $37.70M |
| Other Non-Current Assets | $352.00M | $336.00M | $-4.93B | $-1.75B | $-1.52B |
| Total Non-Current Assets | $8.47B | $8.43B | $8.68B | $2.98B | $2.74B |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $10.55B | $11.13B | $11.92B | $4.32B | $5.58B |
| Account Payables | $315.00M | $357.00M | $351.00M | $104.00M | $102.30M |
| Short Term Debt | $1.30B | $1.26B | $1.48B | $538.00M | $1.66B |
| Tax Payables | $134.00M | $48.00M | $60.00M | $60.50M | $80.00M |
| Deferred Revenue | $- | $- | $259.00M | $166.30M | $159.30M |
| Other Current Liabilities | $827.00M | $913.00M | $954.00M | $687.10M | $697.00M |
| Total Current Liabilities | $2.58B | $2.58B | $2.85B | $1.39B | $2.70B |
| Long Term Debt | $2.84B | $3.47B | $3.99B | $1.43B | $1.48B |
| Deferred Revenue Non-Current | $- | $- | $332.00M | $139.20M | $141.80M |
| Deferred Tax Liabilities Non-Current | $- | $- | $511.00M | $108.10M | $94.70M |
| Other Non-Current Liabilities | $909.00M | $989.00M | $988.00M | $240.60M | $175.60M |
| Total Non-Current Liabilities | $3.75B | $4.46B | $4.98B | $1.67B | $1.75B |
| Other Liabilities | $- | $- | $- | $- | $1 |
| Total Liabilities | $6.33B | $7.04B | $7.82B | $3.06B | $4.45B |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $25.00M | $25.00M | $25.00M | $18.60M | $18.50M |
| Retained Earnings | $3.61B | $3.52B | $6.30B | $3.17B | $3.03B |
| Accumulated Other Comprehensive Income Loss | $- | $- | $-2.23B | $-1.93B | $-1.93B |
| Other Total Stockholders Equity | $598.00M | $546.00M | $9.00M | $7.60M | $6.80M |
| Total Stockholders Equity | $4.23B | $4.09B | $4.10B | $1.26B | $1.13B |
| Total Equity | $4.23B | $4.09B | $4.10B | $1.26B | $1.13B |
| Total Liabilities and Stockholders Equity | $10.55B | $11.13B | $11.92B | $4.32B | $5.58B |
| Minority Interest | $-1.00M | $-1.00M | $-1.00M | $-500.00K | $900.00K |
| Total Liabilities and Total Equity | $10.55B | $11.13B | $11.92B | $4.32B | $5.58B |
| Total Investments | $66.00M | $65.00M | $188.00M | $55.60M | $249.70M |
| Total Debt | $4.14B | $4.73B | $5.40B | $1.93B | $3.14B |
| Net Debt | $3.22B | $3.19B | $3.23B | $1.26B | $1.19B |
Balance Sheet Charts
| Breakdown | December 31, 2024 | June 30, 2024 | December 31, 2023 | June 30, 2023 | December 31, 2022 | June 30, 2022 | December 31, 2021 | June 30, 2021 | December 31, 2020 | June 30, 2020 | December 31, 2019 | June 30, 2019 | December 31, 2018 | June 30, 2018 | December 31, 2017 | June 30, 2017 | December 31, 2016 | June 30, 2016 | December 31, 2015 | June 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $925.00M | $1.56B | $1.56B | $1.42B | $2.17B | $2.37B | $668.40M | $1.56B | $2.23B | $973.60M | $309.60M | $449.40M | $129.80M | $161.40M | $310.10M | $499.50M | $160.20M | $116.90M | $102.60M | $167.90M |
| Short Term Investments | $2.00M | $1.00M | $1.00M | $1.00M | $1.00M | $3.70M | $1.60M | $172.10M | $172.20M | $2.70M | $1.70M | $3.00M | $2.50M | $1.40M | $500.00K | $3.20M | $9.60M | $4.90M | $99.30M | $98.50M |
| Cash and Short Term Investments | $927.00M | $1.56B | $1.56B | $1.42B | $2.17B | $2.37B | $670.00M | $1.73B | $2.40B | $976.30M | $311.30M | $452.40M | $132.30M | $162.80M | $310.60M | $502.70M | $171.10M | $128.30M | $201.90M | $267.60M |
| Net Receivables | $909.00M | $949.00M | $880.00M | $859.00M | $830.00M | $609.90M | $527.00M | $513.20M | $504.60M | $593.00M | $434.80M | $542.10M | $412.60M | $491.10M | $374.30M | $462.00M | $316.10M | $383.30M | $270.20M | $312.80M |
| Inventory | $229.00M | $204.00M | $207.00M | $209.00M | $200.00M | $172.40M | $135.70M | $130.90M | $131.30M | $148.60M | $106.50M | $116.10M | $103.20M | $100.40M | $84.30M | $88.70M | $80.00M | $68.80M | $55.70M | $58.50M |
| Other Current Assets | $22.00M | $19.00M | $33.00M | $35.00M | $- | $29.50M | $8.90M | $9.60M | $81.20M | $7.80M | $73.00M | $17.30M | $93.40M | $18.50M | $94.90M | $45.00M | $256.20M | $12.70M | $70.90M | $6.30M |
| Total Current Assets | $2.09B | $2.73B | $2.70B | $2.52B | $3.24B | $3.19B | $1.34B | $2.39B | $3.09B | $1.73B | $925.70M | $1.13B | $741.50M | $772.80M | $864.10M | $1.10B | $823.40M | $593.10M | $598.70M | $645.20M |
| Property Plant Equipment Net | $963.00M | $959.00M | $951.00M | $941.00M | $949.00M | $671.40M | $625.60M | $604.60M | $620.20M | $629.60M | $612.90M | $612.50M | $436.90M | $408.10M | $390.20M | $382.10M | $416.30M | $553.50M | $477.10M | $460.10M |
| Goodwill | $5.16B | $- | $5.02B | $- | $5.12B | $- | $1.84B | $- | $1.61B | $- | $1.34B | $- | $1.16B | $- | $972.20M | $- | $736.00M | $- | $597.30M | $- |
| Intangible Assets | $1.93B | $7.13B | $2.03B | $7.10B | $7.32B | $2.50B | $2.16B | $1.94B | $1.92B | $1.76B | $1.67B | $1.60B | $338.60M | $1.36B | $234.80M | $1.20B | $251.40M | $935.00M | $212.00M | $434.00M |
| Goodwill and Intangible Assets | $7.09B | $7.13B | $7.04B | $7.10B | $12.44B | $2.50B | $4.01B | $1.94B | $3.53B | $1.76B | $3.02B | $1.60B | $1.50B | $1.36B | $1.21B | $1.20B | $987.40M | $935.00M | $809.30M | $434.00M |
| Long Term Investments | $64.00M | $82.00M | $167.00M | $197.00M | $187.00M | $54.30M | $54.00M | $64.30M | $77.50M | $51.00M | $50.30M | $304.50M | $291.90M | $291.10M | $278.90M | $275.30M | $18.00M | $26.80M | $17.80M | $17.60M |
| Tax Assets | $- | $- | $43.00M | $46.00M | $43.00M | $43.70M | $41.60M | $36.50M | $37.70M | $30.60M | $29.30M | $5.30M | $3.50M | $3.90M | $3.40M | $1.50M | $2.00M | $1.00M | $2.00M | $2.90M |
| Other Non-Current Assets | $352.00M | $333.00M | $227.00M | $185.00M | $-4.93B | $85.20M | $-1.75B | $88.80M | $-1.52B | $101.50M | $-1.24B | $102.00M | $-3.50M | $-3.90M | $-3.40M | $-1.50M | $-2.00M | $-1.00M | $-2.00M | $-2.90M |
| Total Non-Current Assets | $8.47B | $8.50B | $8.43B | $8.47B | $8.68B | $3.35B | $2.98B | $2.74B | $2.74B | $2.58B | $2.47B | $2.62B | $2.22B | $2.06B | $1.88B | $1.86B | $1.42B | $1.52B | $1.30B | $911.70M |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $1 | $- | $- | $1 | $115.80M | $451.20M | $367.50M | $281.40M | $297.70M | $348.10M | $257.90M | $215.30M |
| Total Assets | $10.55B | $11.23B | $11.13B | $10.99B | $11.92B | $6.54B | $4.32B | $5.13B | $5.84B | $4.30B | $3.39B | $3.75B | $3.08B | $3.28B | $3.11B | $3.24B | $2.54B | $2.46B | $2.16B | $1.77B |
| Account Payables | $315.00M | $1.15B | $357.00M | $1.19B | $351.00M | $905.30M | $104.00M | $786.50M | $102.30M | $806.30M | $115.00M | $646.10M | $108.70M | $593.30M | $152.30M | $434.30M | $119.80M | $472.10M | $93.20M | $362.50M |
| Short Term Debt | $1.30B | $1.37B | $1.29B | $869.00M | $1.48B | $687.50M | $538.00M | $1.42B | $1.66B | $740.10M | $1.02B | $607.70M | $521.50M | $37.70M | $68.00M | $388.30M | $77.40M | $172.70M | $354.30M | $333.00M |
| Tax Payables | $134.00M | $46.00M | $48.00M | $50.00M | $60.00M | $78.00M | $60.50M | $86.10M | $80.00M | $77.00M | $72.90M | $66.40M | $133.20M | $79.40M | $137.70M | $79.00M | $127.50M | $77.10M | $129.60M | $67.50M |
| Deferred Revenue | $- | $- | $48.00M | $50.00M | $60.00M | $78.00M | $60.50M | $86.10M | $80.00M | $77.00M | $72.90M | $66.40M | $-115.70M | $-37.70M | $-68.00M | $-388.30M | $-77.40M | $-172.70M | $-332.60M | $-333.00M |
| Other Current Liabilities | $827.00M | $68.00M | $881.00M | $125.00M | $954.00M | $27.50M | $687.10M | $39.30M | $1.11B | $-127.80M | $-288.30M | $43.40M | $481.20M | $29.50M | $355.80M | $109.50M | $354.90M | $66.80M | $275.50M | $28.60M |
| Total Current Liabilities | $2.58B | $2.63B | $2.58B | $2.24B | $2.85B | $1.70B | $1.39B | $2.33B | $2.96B | $1.65B | $915.80M | $1.36B | $1.24B | $739.90M | $713.80M | $1.01B | $679.60M | $788.70M | $852.60M | $791.60M |
| Long Term Debt | $2.84B | $3.48B | $3.49B | $3.90B | $3.99B | $3.11B | $1.43B | $1.45B | $1.48B | $1.28B | $1.20B | $1.26B | $744.10M | $1.21B | $1.14B | $1.13B | $1.29B | $1.09B | $865.40M | $650.70M |
| Deferred Revenue Non-Current | $- | $- | $318.00M | $325.00M | $332.00M | $149.70M | $139.20M | $134.50M | $141.80M | $141.80M | $144.70M | $141.60M | $620.80M | $1.06B | $1.03B | $1.01B | $7.70M | $923.90M | $3.20M | $558.30M |
| Deferred Tax Liabilities Non-Current | $- | $- | $517.00M | $503.00M | $511.00M | $128.00M | $108.10M | $90.60M | $94.70M | $114.70M | $110.80M | $93.10M | $96.00M | $130.50M | $109.30M | $95.30M | $112.80M | $141.00M | $112.80M | $76.90M |
| Other Non-Current Liabilities | $909.00M | $957.00M | $973.00M | $905.00M | $988.00M | $293.00M | $240.60M | $212.00M | $175.60M | $303.10M | $161.50M | $265.50M | $-27.30M | $-155.20M | $- | $-26.90M | $-172.30M | $-21.30M | $-114.80M | $-15.50M |
| Total Non-Current Liabilities | $3.75B | $4.44B | $4.46B | $4.80B | $4.98B | $3.40B | $1.67B | $1.66B | $1.75B | $1.58B | $1.48B | $1.53B | $716.80M | $1.19B | $1.14B | $1.10B | $1.23B | $1.06B | $866.60M | $635.20M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $287.50M | $328.10M | $317.40M | $290.50M | $268.00M | $285.40M | $229.50M | $203.80M |
| Total Liabilities | $6.33B | $7.07B | $7.04B | $7.04B | $7.82B | $5.10B | $3.06B | $3.99B | $4.71B | $3.23B | $2.39B | $2.89B | $2.25B | $2.25B | $2.17B | $2.41B | $2.18B | $2.14B | $1.95B | $1.63B |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $1.83B | $1.85B | $1.86B | $1.83B | $1.77B | $1.78B | $1.78B | $1.77B |
| Common Stock | $25.00M | $25.00M | $25.00M | $25.00M | $25.00M | $18.60M | $18.60M | $18.60M | $18.50M | $18.50M | $18.50M | $18.50M | $18.40M | $18.40M | $18.40M | $18.40M | $18.30M | $18.30M | $18.20M | $18.20M |
| Retained Earnings | $3.61B | $3.58B | $6.52B | $6.38B | $6.30B | $3.19B | $3.17B | $3.05B | $3.03B | $2.90B | $2.84B | $2.66B | $2.64B | $2.86B | $2.77B | $2.64B | $2.11B | $2.07B | $1.97B | $1.89B |
| Accumulated Other Comprehensive Income Loss | $- | $548.00M | $-2.47B | $-2.46B | $-2.23B | $-1.78B | $-1.93B | $-1.94B | $-1.93B | $-1.85B | $-1.87B | $-1.83B | $-1.83B | $-1.85B | $-1.86B | $-1.83B | $-1.77B | $-1.78B | $-1.78B | $-1.77B |
| Other Total Stockholders Equity | $598.00M | $14.00M | $14.00M | $12.00M | $9.00M | $6.80M | $7.60M | $17.20M | $6.80M | $6.80M | $6.80M | $6.80M | $-3.66B | $-3.70B | $-3.71B | $-3.66B | $-3.54B | $-3.55B | $-3.55B | $-3.53B |
| Total Stockholders Equity | $4.23B | $4.16B | $4.09B | $3.95B | $4.10B | $1.44B | $1.26B | $1.14B | $1.13B | $1.07B | $1.00B | $858.40M | $832.20M | $1.03B | $933.70M | $834.00M | $360.60M | $317.30M | $212.30M | $141.50M |
| Total Equity | $4.23B | $4.16B | $4.09B | $3.95B | $4.10B | $1.44B | $1.26B | $1.14B | $1.13B | $1.07B | $1.00B | $858.70M | $832.60M | $1.03B | $934.00M | $834.20M | $360.70M | $317.50M | $212.10M | $141.60M |
| Total Liabilities and Stockholders Equity | $10.55B | $11.23B | $11.13B | $10.99B | $11.92B | $6.54B | $4.32B | $5.13B | $5.84B | $4.30B | $3.39B | $3.75B | $3.08B | $3.28B | $3.11B | $3.24B | $2.54B | $2.46B | $2.16B | $1.77B |
| Minority Interest | $-1.00M | $-1.00M | $-1.00M | $-1.00M | $-1.00M | $-500.00K | $-500.00K | $-400.00K | $900.00K | $700.00K | $600.00K | $300.00K | $400.00K | $400.00K | $300.00K | $200.00K | $100.00K | $200.00K | $-200.00K | $100.00K |
| Total Liabilities and Total Equity | $10.55B | $11.23B | $11.13B | $10.99B | $11.92B | $6.54B | $4.32B | $5.13B | $5.84B | $4.30B | $3.39B | $3.75B | $3.08B | $3.28B | $3.11B | $3.24B | $2.54B | $2.46B | $2.16B | $1.77B |
| Total Investments | $66.00M | $83.00M | $168.00M | $198.00M | $188.00M | $58.00M | $55.60M | $236.40M | $249.70M | $53.70M | $52.00M | $307.50M | $294.40M | $292.50M | $279.40M | $278.50M | $27.60M | $31.70M | $117.10M | $116.10M |
| Total Debt | $4.14B | $4.85B | $4.73B | $4.67B | $5.40B | $3.76B | $1.93B | $2.83B | $3.40B | $2.02B | $1.36B | $1.85B | $1.27B | $1.25B | $1.23B | $1.52B | $1.34B | $1.26B | $1.20B | $983.70M |
| Net Debt | $3.22B | $3.30B | $3.17B | $3.25B | $3.23B | $1.38B | $1.26B | $1.27B | $1.17B | $1.04B | $1.05B | $1.40B | $1.14B | $1.09B | $924.80M | $1.02B | $1.18B | $1.14B | $1.10B | $815.80M |
Annual Cash Flow
| Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 |
|---|---|---|---|---|---|
| Net Income | $307.00M | $625.00M | $232.00M | $263.20M | $185.90M |
| Depreciation and Amortization | $477.00M | $592.00M | $386.00M | $326.50M | $324.70M |
| Deferred Income Tax | $- | $- | $-851.00M | $-643.50M | $-637.40M |
| Stock Based Compensation | $- | $27.00M | $17.00M | $10.00M | $6.00M |
| Change in Working Capital | $-64.00M | $-63.00M | $-3.00M | $18.80M | $24.80M |
| Accounts Receivables | $-38.00M | $-29.00M | $5.00M | $58.70M | $-40.90M |
| Inventory | $-12.00M | $-15.00M | $-4.00M | $-3.20M | $-23.30M |
| Accounts Payables | $- | $-60.00M | $-75.00M | $-43.00M | $78.20M |
| Other Working Capital | $-14.00M | $41.00M | $71.00M | $6.30M | $10.80M |
| Other Non Cash Items | $-42.00M | $-444.00M | $835.00M | $599.10M | $635.10M |
| Net Cash Provided by Operating Activities | $678.00M | $737.00M | $604.00M | $567.10M | $535.10M |
| Investments in Property Plant and Equipment | $-171.00M | $-167.00M | $-190.00M | $-159.90M | $-152.50M |
| Acquisitions Net | $-172.00M | $-228.00M | $-1.01B | $-455.70M | $-186.20M |
| Purchases of Investments | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $- | $- | $- |
| Other Investing Activities | $-30.00M | $-21.00M | $1.00M | $170.60M | $-170.50M |
| Net Cash Used for Investing Activities | $-373.00M | $-416.00M | $-1.20B | $-445.00M | $-509.20M |
| Debt Repayment | $-514.00M | $- | $1.54B | $-250.00M | $253.00M |
| Common Stock Issued | $- | $- | $-16.00M | $-88.00M | $- |
| Common Stock Repurchased | $- | $- | $-104.00M | $-9.40M | $- |
| Dividends Paid | $-229.00M | $-201.00M | $-122.00M | $-138.70M | $- |
| Other Financing Activities | $-9.00M | $-160.00M | $-94.00M | $-28.00M | $-24.00M |
| Net Cash Used Provided by Financing Activities | $-752.00M | $-361.00M | $1.32B | $-417.10M | $253.50M |
| Effect of Forex Changes on Cash | $-13.00M | $-7.00M | $-89.00M | $-14.00M | $-3.00M |
| Net Change in Cash | $-460.00M | $-47.00M | $1.50B | $-1.28B | $780.30M |
| Cash at End of Period | $372.00M | $832.00M | $2.17B | $668.40M | $1.95B |
| Cash at Beginning of Period | $832.00M | $879.00M | $668.40M | $1.95B | $1.17B |
| Operating Cash Flow | $678.00M | $737.00M | $604.00M | $567.10M | $535.10M |
| Capital Expenditure | $-171.00M | $-211.00M | $-190.00M | $-159.90M | $-152.50M |
| Free Cash Flow | $507.00M | $526.00M | $414.00M | $407.20M | $382.60M |
Cash Flow Charts
| Breakdown | December 31, 2024 | June 30, 2024 | December 31, 2023 | June 30, 2023 | December 31, 2022 | June 30, 2022 | December 31, 2021 | June 30, 2021 | December 31, 2020 | June 30, 2020 | December 31, 2019 | June 30, 2019 | December 31, 2018 | June 30, 2018 | December 31, 2017 | June 30, 2017 | December 31, 2016 | June 30, 2016 | December 31, 2015 | June 30, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $111.00M | $196.00M | $196.00M | $185.00M | $107.80M | $124.20M | $144.00M | $119.20M | $138.90M | $47.00M | $195.50M | $88.00M | $-184.60M | $86.30M | $103.40M | $579.60M | $102.70M | $65.10M | $68.50M | $55.80M |
| Depreciation and Amortization | $237.00M | $240.00M | $121.00M | $234.00M | $134.60M | $153.40M | $74.30M | $145.20M | $81.00M | $152.30M | $130.40M | $174.60M | $100.30M | $91.80M | $95.20M | $92.50M | $123.80M | $107.90M | $97.60M | $94.30M |
| Deferred Income Tax | $- | $- | $-306.00M | $- | $-323.30M | $- | $-191.40M | $- | $-131.60M | $- | $-245.70M | $- | $-18.10M | $- | $500.00K | $- | $14.50M | $- | $-11.50M | $- |
| Stock Based Compensation | $- | $- | $27.00M | $- | $17.00M | $- | $10.00M | $- | $2.70M | $- | $2.60M | $- | $2.30M | $- | $1.30M | $- | $900.00K | $- | $300.00K | $- |
| Change in Working Capital | $6.00M | $-70.00M | $-71.00M | $-52.00M | $11.40M | $-14.40M | $-42.90M | $61.70M | $24.70M | $20.90M | $20.80M | $-31.80M | $22.10M | $-54.30M | $-1.80M | $-46.10M | $-15.40M | $-22.80M | $11.20M | $-14.00M |
| Accounts Receivables | $32.00M | $-70.00M | $26.00M | $-55.00M | $55.00M | $-50.00M | $29.50M | $29.20M | $44.30M | $-64.40M | $13.70M | $-51.90M | $14.60M | $-29.00M | $-7.60M | $-38.50M | $-18.60M | $-16.00M | $7.20M | $-12.00M |
| Inventory | $-17.00M | $5.00M | $- | $-15.00M | $17.70M | $-21.70M | $-1.80M | $-1.40M | $12.80M | $-36.10M | $6.20M | $-9.80M | $1.20M | $-12.10M | $5.80M | $-7.60M | $3.20M | $-6.80M | $4.00M | $-2.00M |
| Accounts Payables | $- | $-62.00M | $-63.00M | $3.00M | $-121.80M | $46.80M | $-67.50M | $24.50M | $-24.00M | $102.20M | $-2.20M | $22.40M | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Working Capital | $-9.00M | $57.00M | $-34.00M | $15.00M | $60.50M | $10.50M | $-3.10M | $9.40M | $-8.40M | $19.20M | $3.10M | $7.50M | $6.30M | $-13.20M | $- | $- | $- | $- | $- | $- |
| Other Non Cash Items | $17.00M | $-59.00M | $442.00M | $500.00M | $407.00M | $330.00M | $248.30M | $243.80M | $199.40M | $323.50M | $181.60M | $365.80M | $266.10M | $33.60M | $-8.20M | $-436.10M | $-9.80M | $8.80M | $2.30M | $4.00M |
| Net Cash Provided by Operating Activities | $371.00M | $307.00M | $409.00M | $332.00M | $342.50M | $261.50M | $235.30M | $331.80M | $315.10M | $240.80M | $285.20M | $208.10M | $206.20M | $157.40M | $189.90M | $189.90M | $202.20M | $159.00M | $179.90M | $140.10M |
| Investments in Property Plant and Equipment | $-87.00M | $-84.00M | $-109.00M | $-102.00M | $-106.90M | $-83.10M | $-88.30M | $-71.60M | $-79.40M | $-73.10M | $-85.70M | $-85.20M | $-75.00M | $-72.20M | $-67.00M | $-107.30M | $-97.20M | $-89.00M | $-81.80M | $-77.40M |
| Acquisitions Net | $-96.00M | $-76.00M | $-55.00M | $-173.00M | $-888.20M | $-123.80M | $-193.20M | $-262.50M | $-142.90M | $-43.30M | $198.50M | $-119.10M | $-133.50M | $-164.90M | $-74.30M | $-206.80M | $-81.60M | $-27.60M | $-336.50M | $-32.70M |
| Purchases of Investments | $- | $- | $-12.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Sales Maturities of Investments | $- | $- | $19.00M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Investing Activities | $-10.00M | $-20.00M | $12.00M | $-19.00M | $2.10M | $-2.10M | $170.50M | $100.00K | $-167.30M | $-5.60M | $389.00M | $5.70M | $-2.30M | $-8.90M | $49.20M | $391.70M | $900.00K | $-5.00M | $-2.00M | $-1.50M |
| Net Cash Used for Investing Activities | $-193.00M | $-180.00M | $-145.00M | $-275.00M | $-992.00M | $-209.00M | $-111.00M | $-334.00M | $-222.30M | $-116.40M | $112.80M | $-204.30M | $-210.80M | $-246.00M | $-92.10M | $77.60M | $-177.90M | $-121.60M | $-420.30M | $-111.60M |
| Debt Repayment | $- | $-76.00M | $- | $-82.00M | $- | $1.56B | $- | $-49.80M | $- | $519.50M | $- | $377.70M | $- | $-6.80M | $- | $206.00M | $- | $-108.60M | $- | $32.10M |
| Common Stock Issued | $- | $- | $- | $- | $-3.00M | $-13.00M | $-45.80M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Repurchased | $- | $- | $- | $- | $-58.70M | $-45.30M | $-9.40M | $- | $- | $- | $- | $- | $- | $- | $-100.00K | $- | $-100.00K | $- | $- | $- |
| Dividends Paid | $-80.00M | $-149.00M | $-70.00M | $-131.00M | $-42.40M | $-79.60M | $-38.70M | $-100.00M | $- | $- | $-27.70M | $-58.10M | $-24.00M | $-50.20M | $-20.80M | $-43.50M | $-18.00M | $-37.50M | $-15.80M | $-33.10M |
| Other Financing Activities | $-441.00M | $-6.00M | $-75.00M | $-3.00M | $-105.20M | $-12.80M | $-226.80M | $-1.80M | $-267.10M | $100.00K | $-512.90M | $-300.00K | $-36.70M | $2.00M | $-269.20M | $-37.00M | $-19.10M | $116.40M | $188.50M | $-47.80M |
| Net Cash Used Provided by Financing Activities | $-521.00M | $-231.00M | $-145.00M | $-216.00M | $-147.60M | $1.47B | $-265.50M | $-151.60M | $-457.40M | $519.60M | $-540.60M | $319.30M | $-60.70M | $-55.00M | $-290.10M | $125.50M | $-37.20M | $-29.70M | $172.70M | $-48.80M |
| Effect of Forex Changes on Cash | $-1.00M | $-12.00M | $15.00M | $-22.00M | $-112.00M | $23.00M | $-4.90M | $-9.10M | $-11.20M | $8.70M | $-12.60M | $5.10M | $10.80M | $-5.10M | $2.00M | $-4.50M | $3.80M | $6.80M | $900.00K | $-6.50M |
| Net Change in Cash | $-716.00M | $716.00M | $144.00M | $-752.00M | $-201.10M | $1.70B | $-894.00M | $-663.20M | $1.25B | $664.00M | $-119.50M | $328.20M | $-54.50M | $-148.70M | $-190.30M | $388.50M | $-9.10M | $14.50M | $-66.80M | $-26.80M |
| Cash at End of Period | $- | $716.00M | $1.56B | $1.42B | $2.17B | $2.37B | $668.40M | $1.56B | $2.23B | $973.60M | $309.60M | $449.40M | $100.90M | $155.40M | $304.10M | $494.40M | $105.90M | $115.00M | $100.50M | $167.30M |
| Cash at Beginning of Period | $716.00M | $- | $1.42B | $2.17B | $2.37B | $668.40M | $1.56B | $2.23B | $973.60M | $309.60M | $429.10M | $121.20M | $155.40M | $304.10M | $494.40M | $105.90M | $115.00M | $100.50M | $167.30M | $194.10M |
| Operating Cash Flow | $371.00M | $307.00M | $409.00M | $332.00M | $342.50M | $261.50M | $235.30M | $331.80M | $315.10M | $240.80M | $285.20M | $208.10M | $206.20M | $157.40M | $189.90M | $189.90M | $202.20M | $159.00M | $179.90M | $140.10M |
| Capital Expenditure | $-87.00M | $-84.00M | $-109.00M | $-102.00M | $-106.90M | $-83.10M | $-88.30M | $-71.60M | $-79.40M | $-73.10M | $-85.70M | $-85.20M | $-75.00M | $-72.20M | $-67.00M | $-107.30M | $-97.20M | $-89.00M | $-81.80M | $-77.40M |
| Free Cash Flow | $284.00M | $223.00M | $300.00M | $230.00M | $235.60M | $178.40M | $147.00M | $260.20M | $235.70M | $167.70M | $199.50M | $122.90M | $131.20M | $85.20M | $122.90M | $82.60M | $105.00M | $70.00M | $98.10M | $62.70M |
Rentokil Initial plc Dividends
Explore Rentokil Initial plc's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
2.27%
Dividend Payout Ratio
74.59%
Dividend Paid & Capex Coverage Ratio
1.53x
Rentokil Initial plc Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.38249 | $0.38249 | April 04, 2025 | April 04, 2025 | May 15, 2025 | March 06, 2025 |
| $0.20338 | $0.20338 | August 09, 2024 | August 09, 2024 | September 17, 2024 | July 25, 2024 |
| $0.37842 | $0.37842 | April 04, 2024 | April 05, 2024 | May 28, 2024 | |
| $0.17735 | $0.17735 | August 03, 2023 | August 04, 2023 | September 12, 2023 | July 27, 2023 |
| $0.31688 | $0.31688 | April 10, 2023 | April 11, 2023 | May 18, 2023 | March 23, 2023 |
| $0.146 | $0.146 | August 05, 2022 | August 29, 2022 | September 22, 2022 | |
| $0.284 | $0.284 | April 07, 2022 | April 08, 2022 | May 31, 2022 | |
| $0.145 | $0.145 | August 12, 2021 | August 13, 2021 | September 23, 2021 | |
| $0.376 | $0.376 | April 08, 2021 | April 09, 2021 | June 01, 2021 | |
| $0.092 | $0.092 | August 09, 2019 | August 12, 2019 | September 23, 2019 | |
| $0.206 | $0.206 | April 11, 2019 | April 12, 2019 | May 28, 2019 | |
| $0.086 | $0.086 | August 10, 2018 | August 13, 2018 | September 24, 2018 | |
| $0.19 | $0.19 | April 12, 2018 | April 13, 2018 | May 29, 2018 | |
| $0.075 | $0.075 | August 09, 2017 | August 11, 2017 | September 25, 2017 | |
| $0.149 | $0.149 | April 05, 2017 | April 07, 2017 | May 30, 2017 | |
| $0.065 | $0.065 | August 16, 2016 | |||
| $0.148 | $0.148 | April 06, 2016 | |||
| $0.068 | $0.068 | August 12, 2015 | |||
| $0.136 | $0.136 | April 16, 2015 | |||
| $0.065 | $0.065 | August 13, 2014 |
Rentokil Initial plc News
Read the latest news about Rentokil Initial plc, including recent articles, headlines, and updates.
Verisante Technology, Inc. Announces Termination of Proposed RTO with SunRegen Healthcare AG
VANCOUVER, BC / ACCESS Newswire / March 31, 2025 / Verisante Technology, Inc. (TSXV:VER.H) ("Verisante") announces that on March 28, 2025, it mutually agreed with SunRegen Healthcare AG ("SunRegen") to terminate the Letter of Intent ("LOI") dated August 12, 2024, to acquire SunRegen Healthcare AG ("SunRegen"), by way of a Reverse Takeover ("RTO"). Verisante's common shares were previously halted from trading in connection with a proposed RTO with SunRegen Healthcare AG.
Rentokil Initial PLC Announces Annual Financial Report
Annual Report and Annual General Meeting CRAWLEY, GB / ACCESS Newswire / March 26, 2025 / In compliance with Listing Rule 6.4.1, the Company announces that the following documents, in unedited full text, have today been filed with the Financial Conduct Authority and are available for inspection via the National Storage Mechanism at https://data.fca.org.uk/#/nsm/nationalstoragemechanism: Annual Report and Financial Statements for the year ended 31 December 2024 (the Annual Report 2024); Notice of 2025 Annual General Meeting (AGM); and Proxy Form for the 2025 AGM. The documents will be posted today, and the Annual Report 2024 and the Notice of 2025 AGM have been published on the Company's website at rentokil-initial.com/investors.
Rentokil: Industry Tailwinds, A Turnaround, And A High Caliber Activist Investor
The pest control industry is attractive due to its capital-light, non-cyclical nature, providing relatively predictable revenue streams. This feature is being enhanced through greater sales through subscriptions and long-term contracts. Meanwhile, the industry benefits from a growth tailwind due to greater urbanisation, a regulatory push on commercial customers, and global warming potentially increasing insect populations. Rentokil's stock has declined over 50% from its peak price. We believe this is attributed primarily from challenges in integrating the Terminix acquisition. We believe this is a fixable problem.
Rentokil Initial plc (RTO) Q4 2024 Earnings Call Transcript
Rentokil Initial plc (NYSE:RTO ) Q4 2024 Earnings Conference Call March 6, 2025 4:15 AM ET Company Participants Andrew Ransom - Chief Executive Officer Paul Edgecliffe-Johnson - Chief Financial Officer Conference Call Participants Simona Sarli - Bank of America Annelies Vermeulen - Morgan Stanley Suhasini Varanasi - Goldman Sachs Group, Inc. Christopher Bamberry - Peel Hunt LLP Sylvia Barker - JPMorgan Chase & Co. James Beard - Deutsche Bank AG Ollie Davies - Redburn Atlantic Allen Wells - Jefferies James Rosenthal - Barclays Bank Andrew Grobler - BNP Paribas Exane Nicole Manion - UBS Andrew Ransom Good morning, everyone. So here's a quick look at today's agenda.
Rentokil risks remain but clarity on merger issues a positive - analysts
Rentokil Initial PLC gave investors little to cheer about on Thursday with largely expected news that profit tumbled last year on challenges within its North American. Shares dropped 4.4% in the wake of the update, which showed statutory pre-tax profit down 17.9% at £405 million.
Rentokil profit tumbles in ‘challenging' year
Rentokil Initial PLC has firmed up a drop in profit after a “challenging” year on struggles within its North American business. Statutory pre-tax profit dropped 17.9% to £405 million in the year to December 31, as revenue climbed 1.1% to £5.44 billion, the pest-control business said on Thursday.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Rentokil Initial plc of Class Action Lawsuit and Upcoming Deadlines - RTO
NEW YORK , Jan. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Rentokil Initial plc ("Rentokil" or the "Company") (NYSE: RTO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
Rentokil US boss to depart after in-line year
Rentokil Initial PLC has announced the departure of its North American chief executive and said trading matched expectations last year. Brad Paulsen will step down in April and be replaced by chief commercial officer Alain Moffroid on an interim basis, the pest control firm said Tuesday.
Shareholders that lost money on Rentokil Initial plc(RTO) should contact Levi & Korsinsky about pending Class Action - RTO
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Rentokil Initial plc (NYSE:RTO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rentokil-initial-plc-lawsuit-submission-form?prid=125435&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Rentokil Initial plc (RTO) Shareholders
NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Rentokil Initial plc ("Rentokil" or the "Company") (NYSE: RTO) of a class action securities lawsuit.
Lost Money on Rentokil Initial plc(RTO)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Rentokil Initial plc (NYSE:RTO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rentokil-initial-plc-lawsuit-submission-form?prid=125355&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 27, 2025 in Rentokil Initial plc Lawsuit - RTO
NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Rentokil Initial plc (NYSE:RTO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rentokil-initial-plc-lawsuit-submission-form?prid=125335&wire=1 or contact Joseph E. Levi, Esq.
Levi & Korsinsky Reminds Rentokil Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 27, 2025 - RTO
NEW YORK, NY / ACCESS Newswire / January 27, 2025 / If you suffered a loss on your Rentokil Initial plc (NYSE:RTO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rentokil-initial-plc-lawsuit-submission-form?prid=125269&wire=1 or contact Joseph E. Levi, Esq.
FINAL REMINDER RTO DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Rentokil Initial Plc Investors to Participate in the Class Action Lawsuit
NEW YORK CITY, NY / ACCESS Newswire / January 27, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rentokil Initial Plc ("Rentokil" or "the Company") (NYSE:RTO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Rentokil securities between December 01, 2023 and September 10, 2024, both dates inclusive (the "Class Period").
The Gross Law Firm Reminds Rentokil Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 27, 2025 - RTO
NEW YORK , Jan. 27, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rentokil Initial plc (NYSE: RTO). Shareholders who purchased shares of RTO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Contact Levi & Korsinsky by January 27, 2025 Deadline to Join Class Action Against Rentokil Initial plc(RTO)
NEW YORK, NY / ACCESS Newswire / January 26, 2025 / If you suffered a loss on your Rentokil Initial plc (NYSE:RTO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rentokil-initial-plc-lawsuit-submission-form?prid=125219&wire=1 or contact Joseph E. Levi, Esq.
RTO DEADLINE TOMORROW: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Rentokil Initial plc Investors to Secure Counsel Before Important January 27 Deadline in Securities Class Action - RTO
NEW YORK, NY / ACCESS Newswire / January 26, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares ("ADS") of Rentokil Initial plc (NYSE:RTO) between December 1, 2023 and September 10, 2024, both dates inclusive (the "Class Period"), of the important January 27, 2025 lead plaintiff deadline. SO WHAT: If you purchased Rentokil ADSs during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Shareholders of Rentokil Initial plc Should Contact Levi & Korsinsky Before January 27, 2025 to Discuss Your Rights - RTO
NEW YORK, NY / ACCESS Newswire / January 26, 2025 / If you suffered a loss on your Rentokil Initial plc (NYSE:RTO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rentokil-initial-plc-lawsuit-submission-form?prid=125193&wire=1 or contact Joseph E. Levi, Esq.
Rentokil Initial plc Sued for Securities Law Violations - Contact Levi & Korsinsky Before January 27, 2025 to Discuss Your Rights - RTO
NEW YORK, NY / ACCESS Newswire / January 26, 2025 / If you suffered a loss on your Rentokil Initial plc (NYSE:RTO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rentokil-initial-plc-lawsuit-submission-form?prid=125169&wire=1 or contact Joseph E. Levi, Esq.
RTO DEADLINE TOMORROW: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Rentokil Initial plc Investors to Secure Counsel Before Important January 27 Deadline in Securities Class Action – RTO
NEW YORK, Jan. 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS”) of Rentokil Initial plc (NYSE: RTO) between December 1, 2023 and September 10, 2024, both dates inclusive (the “Class Period”), of the important January 27, 2025 lead plaintiff deadline.
FINAL RTO DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Rentokil Initial Plc Investors to Join the Class Action Lawsuit
NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rentokil Initial Plc ("Rentokil" or "the Company") (NYSE:RTO) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Rentokil securities between December 01, 2023 and September 10, 2024, both dates inclusive (the "Class Period").
Rentokil Initial plc Class Action: Levi & Korsinsky Reminds Rentokil Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 27, 2025 - RTO
NEW YORK, NY / ACCESS Newswire / January 25, 2025 / If you suffered a loss on your Rentokil Initial plc (NYSE:RTO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rentokil-initial-plc-lawsuit-submission-form?prid=125072&wire=1 or contact Joseph E. Levi, Esq.
RTO Deadline: RTO Investors Have Opportunity to Lead Rentokil Initial plc Securities Fraud Lawsuit
NEW YORK , Jan. 24, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares ("ADS") of Rentokil Initial plc (NYSE: RTO) between December 1, 2023 and September 10, 2024, both dates inclusive (the "Class Period"), of the important January 27, 2025 lead plaintiff deadline. So what: If you purchased Rentokil ADSs during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Class Action Filed Against Rentokil Initial plc (RTO) Seeking Recovery for Investors - Contact Levi & Korsinsky
NEW YORK CITY, NY / ACCESS Newswire / January 24, 2025 / If you suffered a loss on your Rentokil Initial plc (NYSE:RTO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rentokil-initial-plc-lawsuit-submission-form?prid=124973&wire=1 or contact Joseph E. Levi, Esq.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for RTO.